Kimoto Eiji, Shoji Tetsuo, Shinohara Kayo, Hatsuda Sawako, Mori Katsuhito, Fukumoto Shinya, Koyama Hidenori, Emoto Masanori, Okuno Yasuhisa, Nishizawa Yoshiki
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
J Am Soc Nephrol. 2006 Aug;17(8):2245-52. doi: 10.1681/ASN.2005101038. Epub 2006 Jul 12.
Increased arterial stiffness is an independent predictor of death from cardiovascular disease, and aortic stiffness is more predictive than stiffness of other arterial regions. Because little is known about the effect of chronic kidney disease (CKD) on regional arterial stiffness, pulse wave velocity (PWV) of four different arterial segments was measured in patients who had type 2 diabetes with and without various stages of CKD. A total of 434 patients had type 2 diabetes, and there were 192 healthy control subjects who were comparable in age and gender. GFR was estimated by the abbreviated Modification of Diet in Renal Disease equation. The patients with diabetes were classified into CKD stages by the definition of the Kidney Disease Outcomes Quality Initiative guidelines. PWV was measured in the heart-femoral, heart-carotid, heart-brachial, and femoral-ankle segments simultaneously using an automatic pulse wave analyzer. PWV of each arterial region was increased in patients who had diabetes without kidney damage and was increased further in a stepwise manner with the advanced stages of CKD. The increase in PWV was greater in the heart-femoral and heart-carotid regions than in the heart-brachial and femoral-ankle segments. However, after adjustment for age, BP, and other confounding factors using a multiple regression model, decreased GFR was independently associated with increased PWV of the heart-femoral region but not with PWV of other arterial segments. In type 2 diabetes, CKD was associated with increased stiffness of arteries, particularly of the aorta. The cross-sectional result may explain the increased risk for cardiovascular disease in CKD, although longitudinal studies are needed to confirm it.
动脉僵硬度增加是心血管疾病死亡的独立预测因素,且主动脉僵硬度比其他动脉区域的僵硬度更具预测性。由于关于慢性肾脏病(CKD)对局部动脉僵硬度的影响知之甚少,因此对患有2型糖尿病且伴有或不伴有不同阶段CKD的患者测量了四个不同动脉节段的脉搏波速度(PWV)。共有434例2型糖尿病患者,另有192名年龄和性别匹配的健康对照者。采用简化的肾脏病膳食改良方程估算肾小球滤过率(GFR)。根据肾脏病预后质量倡议指南的定义,将糖尿病患者分为CKD各期。使用自动脉搏波分析仪同时测量心脏-股动脉、心脏-颈动脉、心脏-肱动脉和股动脉-踝动脉节段的PWV。在无肾脏损害的糖尿病患者中,各动脉区域的PWV均升高,且随着CKD病情进展呈逐步升高。心脏-股动脉和心脏-颈动脉区域PWV的升高幅度大于心脏-肱动脉和股动脉-踝动脉节段。然而,在使用多元回归模型校正年龄、血压和其他混杂因素后,GFR降低与心脏-股动脉区域PWV升高独立相关,而与其他动脉节段的PWV无关。在2型糖尿病中,CKD与动脉僵硬度增加有关,尤其是主动脉。尽管需要纵向研究来证实,但横断面研究结果可能解释了CKD患者心血管疾病风险增加的原因。